Modulation of p53 expression and its role in the conversion to a fully immortalized chicken embryo fibroblast line

FEBS Letters

Volumn 579, Issue 30, 2005, Pages 6705-6715

  Christman, Shelly A ^a   Kong, Byung Whi ^a   Landry, Megan M ^a   Kim, Hyunggee ^b   Foster, Douglas N ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Korea University   (South Korea)

Author keywords

Chicken embryo fibroblast cell line; p15INK4b; p53; Spontaneous immortalization

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; PROTEIN MDM2; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL IMMORTALIZATION; CHICKEN; CONTROLLED STUDY; EMBRYO; FIBROBLAST CULTURE; FLUORESCENCE ACTIVATED CELL SORTER; FUNCTIONAL ANATOMY; GROWTH RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL CYCLE; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLOHEXIMIDE; FIBROBLASTS; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENE SILENCING; GENES, REPORTER; LUCIFERASES; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 28844504698     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.10.066     Document Type: Article

References (74)

1. J. Campisi The molecular basis of cell cycle and growth control G. Stein R. Baserga A. Giordano D. Denhardt Replicative Senescence and Immortalization 1999 Wiley-Liss New York, NY 348 373
2. C.J. Sherr, and R.A. DePinho Cellular senescence: mitotic clock or culture shock? Cell 102 2000 407 410
3. L. Hayflick, and P.S. Moorehead The serial cultivation of human diploid cell strains Exp. Cell Res. 25 1961 585 621
4. J.M. Sedivy Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells Proc. Natl. Acad. Sci. USA 95 1998 9078 9081
5. A. Aviv, and C.B. Harley How long should telomeres be? Curr. Hypertens. Rep. 3 2001 145 151
6. M.Z. Levy, R.C. Allsopp, A.B. Futcher, C.W. Greider, and C.B. Harley Telomere end-replication problem and cell aging J. Mol. Biol. 225 1992 951 960
7. C.W. Greider Telomere length regulation Annu. Rev. Biochem. 65 1996 337 365
8. J. Campisi From cells to organisms: can we learn about aging from cells in culture? Exp. Gerontol. 36 2001 607 618
9. A.J. Levine, A. Chang, D. Dittmer, D.A. Notterman, A. Silver, K. Thorn, D. Welsh, and M. Wu The p53 tumor suppressor gene J. Lab. Clin. Med. 123 1994 817 823
10. D.B. Woods, and K.H. Vousden Regulation of p53 function Exp. Cell Res. 264 2001 56 66
11. X.W. Wu, J.H. Bayle, D. Olson, and A.J. Levine The p53 mdm-2 autoregulatory feedback loop Genes Dev. 7 1993 1126 1132
12. A.J. Giaccia, and M.B. Kastan The complexity of p53 modulation: emerging patterns from divergent signals Genes Dev. 12 1998 2973 2983
13. W.S. El-Diery, T. Tokino, V. Velculescu, D. Levy, R. Parsons, J. Trent, D. Lin, E. Mercer, K. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
14. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
15. L.D. Attardi, E.E. Reczek, C. Cosmas, E.G. Demicco, M.E. McCurrach, S.W. Lowe, and T. Jacks PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes Dev. 14 2000 704 718
16. E. Oda, R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 288 2000 1053 1058
17. L.J. Ko, and C. Prives p53: puzzle and paradigm Genes Dev. 10 1996 1054 1072
18. B.D. Dynlacht, C. Ngwu, J. Winston, E.C. Swindell, S.J. Elledge, E. Harlow, and J.W. Harper Purification and analysis of CIP/KIP proteins Methods Enzymol. 283 1997 230 244
19. Cip1 cdk inhibitor family is a candidate tumor suppressor gene Genes Dev. 9 1995 650 662
20. M.R. Stampfer, J. Garbe, T. Nijjar, D. Wigington, K. Swisshelm, and P. Yaswen Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines Oncogene 22 2003 5238 5251
21. M. Serrano, G. Hannon, and D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707
22. C.J. Sherr Cancer Cell Cycles Science 274 1996 1672 1677
23. M. Serrano The tumor suppressor protein p16INK4a Exp. Cell Res. 237 1997 7 13
24. N.E. Sharpless, and R.A. DePinho The INK4A/ARF locus and its two gene products Curr. Opin. Gen. Dev. 9 1999 22 30
25. C.J. Sherr The INK4a/ARF network in tumour suppression Nat. Rev. Mol. Cell Biol. 2 2001 731 737
26. A. Lloyd p53: only ARF the story Nat. Cell Biol. 2 2000 E48 E50
27. ARF Cell 91 1997 649 659
28. M. Himly, D.N. Foster, I. Bottoli, J.S. Lacovoni, and P.K. Vogt The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leucosis viruses Virology 248 1998 295 408
29. H. Kim, S. You, I.-J. Kim, L.K. Foster, J. Farris, S. Ambady, F.A. Ponce de Leon, and D.N. Foster Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts Oncogene 20 2001 2671 2682
30. D.W. Felsher, and J.M. Bishop Transient excess of MYC activity can elicit genomic instability and tumorigenesis Proc. Natl. Acad. Sci. USA 96 1999 3940 3944
31. M.S. Rodriguez, J.M. Desterro, S. Lain, C.A. Midgley, D.P. Lane, and R.T. Hay SUMO-1 modification activates the transcriptional response of p53 EMBO J. 18 1999 6455 6461
32. J. Garbe, M. Wong, D. Wigington, P. Yaswen, and M.R. Stampfer Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells Oncogene 18 1999 2169 2180
33. KIP2 expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells Cancer Res. 59 1999 5112 5118
34. N.M. Yeilding, W.N. Procopio, M.T. Rehman, and W.M.F. Lee c-myc mRNA is downregulated during myogenic differentiation by accelerated decay that depends on translation of regulatory coding elements J. Biol. Chem. 273 1998 15749 15757
35. H. Kim, S. You, L.K. Foster, J. Farris, and D.N. Foster The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells Oncogene 20 2001 5118 5123
36. B. Bienz, R. Zakut-Houri, D. Givol, and M. Oren Analysis of the gene coding for the murine cellular tumor antigen p53 EMBO J. 3 1984 2179 2183
37. J. Momand, G.P. Zambetti, D.C. Olson, D. George, and A.J. Levine The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1992 1237 1245
38. J.D. Oliner, J.A. Pietenpol, S. Thiagalingam, J. Gyuris, K.W. Kinzler, and B. Vogelstein Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature 362 1993 857 860
39. Y. Barak, T. Juven, R. Haffner, and M. Oren mdm2 expression is induced by wild type p53 activity EMBO J. 12 1993 461 468
40. Y. Gu, C. Turek, and D. Morgan Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit Nature 366 1993 707 710
41. J.W. Harper, G. Adami, N. Wei, K. Keyomarse, and S. Elledge The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
42. A. Koff, M. Ohtsuki, K. Polyak, J. Roberts, and J. Massague Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β Science 260 1993 536 539
43. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest Genes Dev. 8 1994 9 22
44. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Dev. 9 1995 639 649
45. W.S. El-Deiry, J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, and B. Vogelstein WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res. 54 1994 1169 1174
46. A. Noda, Y. Ning, S. Venable, O. Pereira-Smith, and J. Smith Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen Exp. Cell Res. 211 1994 90 98
47. E. Firpo, A. Koff, M. Solomon, and J. Roberts Inactivation of a Cdk2 inhibitor during IL-2 induced proliferation of human T-lymphocytes Mol. Cell. Biol. 14 1994 4889 4901
48. Kip1 cyclin-Cdk kinase inhibitor prevented by rapamycin Nature 372 1994 570 573
49. Kip1 for restriction point control of the fibroblast cell cycle Science 272 1996 877 880
50. K. Polyak, M.-H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst, and J. Massagué Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell 78 1994 59 66
51. H. Toyoshima, and T. Hunter p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 Cell 78 1994 67 74
52. J.J. Huang, J.K. Yee, J.Y. Shew, P.L. Chen, J.R. Bookstein, T. Friedmann, E.Y. Lee, and W.H. Lee Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells Science 242 1988 1563 1566
53. T. Hunter, and J. Pines Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age Cell 79 1994 573 582
54. INK4 in human cancer Proc. Natl. Acad. Sci. USA 91 1994 11045 11049
55. INK4a and truncation of ARF tumor suppressors in chickens Proc. Natl. Acad. Sci. USA 100 2003 211 216
56. INK4a-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells Exp. Cell Res. 272 2002 199 208
57. A. Merlo, J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin, and D. Sidransky 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat. Med. 1 1995 686 692
58. J. Weber, L. Taylor, M. Roussel, C. Sherr, and D. Bar-Sagi Nucleolar Arf sequesters Mdm2 and activates p53 Nat. Cell Biol. 1 1999 20 26
59. ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2 Proc. Natl. Acad. Sci. USA 96 1999 6937 6941
60. Y. Zhang, and Y. Xiong Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53 Mol. Cell 3 1999 579 591
61. G.P. Dimri, E.E. Hara, and J. Campisi Regulation of two E2F-related genes in presenescent and senescent human fibroblasts J. Biol. Chem. 269 1994 16180 16186
62. S. Bates, A.C. Phillips, P.A. Clark, F. Stott, G. Peters, R.L. Ludwig, and K.H. Vousden p14ARF links the tumour suppressors RB andp53 Nature (London) 395 1998 124 125
63. D. Resnitzky, L. Hengst, and S.I. Reed Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1 Mol. Cell. Biol. 15 1995 4347 4352
64. Z.-J. Liu, T. Ueda, T. Miyazaki, N. Tanaka, S. Mine, Y. Tanaka, T. Taniguchi, H. Yamamura, and Y. Minami A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc Mol. Cell. Biol. 18 1998 3445 3454
65. M.H. Ladha, K.Y. Lee, T.M. Upton, M.F. Reed, and M.E. Ewen Regulation of exit from quiescence by p27 and cyclin D1-CDK4 Mol. Cell. Biol. 18 1998 6605 6615
66. M. Ohtsubo, and J.M. Roberts Cyclin-dependent regulation of G1 in mammalian fibroblasts Science 259 1993 1908 1912
67. M. Meyyappan, H. Wong, C. Hull, and K.T. Riabowol Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells Mol. Cell. Biol. 18 1998 3163 3172
68. H.M. Chen, M. Yen-Ping Kuo, K.H. Lin, C.Y. Lin, and C.P. Chiang Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan Oral Oncol. 39 2003 476 482
69. D. Ratschiller, J. Heighway, M. Gugger, A. Kappeler, F. Pirnia, R.A. Schmid, M.M. Borner, and D.C. Betticher Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival J. Clin. Oncol. 21 2003 2085 2093
70. A.C. Minella, J. Swanger, E. Bryant, M. Welcker, H. Hwang, and B.E. Clurman p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation Curr. Biol. 12 2002 1817 1827
71. A.G. Bodnar, M. Ouellette, M. Frolkis, S.E. Holt, C.P. Shiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner, and W.E. Wright Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
72. T.M. Bryan, A. Englezou, J. Gupta, S. Bacchetti, and R.R. Reddel Telomere elongation in immortal human cells without detectable telomerase activity EMBO J. 14 1995 4240 4248
73. T.M. Bryan, L. Marusic, S. Bacchetti, M. Namba, and R.R. Reddel The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit Hum. Mol. Genet. 6 1997 921 926
74. A. Smogorzewska, B. van Steensel, A. Bianchi, S. Oelmann, M.R. Schaefer, G. Schnapp, and T. de Lange Control of human telomere length by TRF1 and TRF2 Mol. Cell. Biol. 20 2000 1659 1668